NCT05788900View on ClinicalTrials.gov

Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration

PHASE1UnknownINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

June 30, 2023

Study Completion Date

September 30, 2023

Conditions
Anticoagulant
Interventions
BIOLOGICAL

Heparin

intravenous Heparin

Sponsors
All Listed Sponsors
lead

Blau Farmaceutica S.A.

INDUSTRY